Justice Thurman 4

What Happened Justice Thurman, a director of LifeStance Health Group, was awarded 35,492 restricted stock units (RSUs) on July 2, 2026. The RSUs were reported at a $0.00 acquisition price (i.e., an award/grant rather than a market purchase); the filing shows 35,492 units were acquired. RSUs are compensation awards that convert to common shares only if and when they vest.

Key Details

• Transaction date: 2026-07-02; reported on Form 4 filed 2026-07-07.
• Price: $0.00 per unit (award/grant), total reported cash consideration $0.
• Shares owned after transaction: Not specified in the filing summary provided.
• Footnote: Filing notes these are 35,492 restricted stock units (RSUs), each representing a contingent right to receive one share of common stock (per footnote F1).
• Timeliness: Filed July 7, 2026 — appears to be within the standard Form 4 reporting window.

Context RSU grants are a common form of director compensation and do not represent an immediate purchase or sale of tradable shares; they vest according to the company’s plan terms before converting to stock. Such awards are informative about compensation but do not, by themselves, indicate the insider is buying or selling shares in the open market.